Skip to Content

Stereotaxis Inc STXS

Morningstar Rating
$2.70 −0.17 (5.92%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

STXS is trading at a 17% discount.
Price
$2.87
Fair Value
$9.41
Uncertainty
Very High
1-Star Price
$3.54
5-Star Price
$8.44
Economic Moat
Nlgd
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if STXS is a good fit for your portfolio.

News

Trading Information

Previous Close Price
$2.87
Day Range
$2.502.89
52-Week Range
$1.333.29
Bid/Ask
$2.66 / $3.00
Market Cap
$218.39 Mil
Volume/Avg
571,876 / 257,994

Key Statistics

Price/Earnings (Normalized)
Price/Sales
7.24
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems; Disposables, Royalty; and Sublease, of which a majority of revenue is generated from the Disposables, service and accessories stream. The company generates the majority of revenue from the United States.
Sector
Healthcare
Industry
Medical Instruments & Supplies
Stock Style Box
Small Value
Total Number of Employees
130

Competitors

Valuation

Metric
STXS
ISRG
Price/Earnings (Normalized)
69.68
Price/Book Value
11.6710.53
Price/Sales
7.2419.96
Price/Cash Flow
54.88
Price/Earnings
STXS
ISRG

Financial Strength

Metric
STXS
ISRG
Quick Ratio
2.103.91
Current Ratio
2.734.76
Interest Coverage
Quick Ratio
STXS
ISRG

Profitability

Metric
STXS
ISRG
Return on Assets (Normalized)
−18.12%14.56%
Return on Equity (Normalized)
−38.89%17.02%
Return on Invested Capital (Normalized)
−29.50%15.43%
Return on Assets
STXS
ISRG
See how this stock stacks up to its competitors with Morningstar Investor

Medical Instruments & Supplies Industry Comparables

Ticker
Name
Morningstar Rating for Stocks
Economic Moat
Market Cap
ISRG
Intuitive Surgical IncPsffg$140.2 Bil
BDX
Becton Dickinson & CoWqscxqq$68.0 Bil
ALC
Alcon IncQsgpj$42.4 Bil
CLPBY
Coloplast A/S ADRLpkn$29.9 Bil
WST
West Pharmaceutical Services IncMljc$26.3 Bil
RMD
ResMed IncQcmtvh$25.7 Bil
BAX
Baxter International IncHnwwky$20.8 Bil
COO
The Cooper Companies IncJwzcjm$20.3 Bil
HOLX
Hologic IncXtmmz$17.3 Bil
TFX
Teleflex IncCnftf$10.5 Bil

Sponsor Center